Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Proia

Showing results (31-40 of 89) with videos related to

Pageof 9
Sort By:
Investigational New Drugs|May 21, 2013
Targeted inhibition of Hsp90 by ganetespib is effective across a broad spectrum of breast cancer subtypesJulie C Friedland, Donald L Smith, Jim Sang, et al.
Annals of Hematology|March 31, 2000
Conventional salvage chemotherapy vs. high-dose therapy with autografting for recurrent or refractory Hodgkin's disease patientsA P Anselmo, G Meloni, E Cavalieri, et al.
Molecular Cancer Research : MCR|February 21, 2014
mTOR inhibition potentiates HSP90 inhibitor activity via cessation of HSP synthesisJaime Acquaviva, Suqin He, Jim Sang, et al.
The Annals of Thoracic Surgery|September 22, 2009
An unusual case of Aspergillus fibrosing mediastinitisSean C Wightman, Anthony W Kim, Laurie A Proia, et al.
Hormones & Cancer|February 10, 2016
Hsp90 Inhibition Results in Glucocorticoid Receptor Degradation in Association with Increased Sensitivity to Paclitaxel in Triple-Negative Breast CancerAbena S Agyeman, Wesley J Jun, David A Proia, et al.
Annals of Hematology|April 27, 2002
Thrombotic thrombocytopenic purpura and pregnancy: a case report and a review of the literatureA Proia, R Paesano, F Torcia, et al.
Targeted Oncology|August 1, 2014
The HSP90 inhibitor ganetespib potentiates the antitumor activity of EGFR tyrosine kinase inhibition in mutant and wild-type non-small cell lung cancerDonald L Smith, Jaime Acquaviva, Manuel Sequeira, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 9, 2008
Clinical practice guidelines for the management of blastomycosis: 2008 update by the Infectious Diseases Society of AmericaStanley W Chapman, William E Dismukes, Laurie A Proia, et al.
Molecular Cancer Therapeutics|September 27, 2012
Targeting KRAS-mutant non-small cell lung cancer with the Hsp90 inhibitor ganetespibJaime Acquaviva, Donald L Smith, Jim Sang, et al.
Journal of Human Virology|June 26, 2002
Chronic stavudine exposure induces hepatic mitochondrial toxicity in adult Erythrocebus patas monkeysM Gerschenson, V T Nguyen, M C St Claire, et al.
Pageof 9

Showing results (31-40 of 89) with videos related to

Sort By:
Pageof 9
Investigational New Drugs|May 21, 2013
Targeted inhibition of Hsp90 by ganetespib is effective across a broad spectrum of breast cancer subtypesJulie C Friedland, Donald L Smith, Jim Sang, et al.
Annals of Hematology|March 31, 2000
Conventional salvage chemotherapy vs. high-dose therapy with autografting for recurrent or refractory Hodgkin's disease patientsA P Anselmo, G Meloni, E Cavalieri, et al.
Molecular Cancer Research : MCR|February 21, 2014
mTOR inhibition potentiates HSP90 inhibitor activity via cessation of HSP synthesisJaime Acquaviva, Suqin He, Jim Sang, et al.
The Annals of Thoracic Surgery|September 22, 2009
An unusual case of Aspergillus fibrosing mediastinitisSean C Wightman, Anthony W Kim, Laurie A Proia, et al.
Hormones & Cancer|February 10, 2016
Hsp90 Inhibition Results in Glucocorticoid Receptor Degradation in Association with Increased Sensitivity to Paclitaxel in Triple-Negative Breast CancerAbena S Agyeman, Wesley J Jun, David A Proia, et al.
Annals of Hematology|April 27, 2002
Thrombotic thrombocytopenic purpura and pregnancy: a case report and a review of the literatureA Proia, R Paesano, F Torcia, et al.
Targeted Oncology|August 1, 2014
The HSP90 inhibitor ganetespib potentiates the antitumor activity of EGFR tyrosine kinase inhibition in mutant and wild-type non-small cell lung cancerDonald L Smith, Jaime Acquaviva, Manuel Sequeira, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 9, 2008
Clinical practice guidelines for the management of blastomycosis: 2008 update by the Infectious Diseases Society of AmericaStanley W Chapman, William E Dismukes, Laurie A Proia, et al.
Molecular Cancer Therapeutics|September 27, 2012
Targeting KRAS-mutant non-small cell lung cancer with the Hsp90 inhibitor ganetespibJaime Acquaviva, Donald L Smith, Jim Sang, et al.
Journal of Human Virology|June 26, 2002
Chronic stavudine exposure induces hepatic mitochondrial toxicity in adult Erythrocebus patas monkeysM Gerschenson, V T Nguyen, M C St Claire, et al.
Pageof 9